TLDR Mesotherapy, a treatment with micronutrients and antioxidants, improves hair growth and thickness, especially in younger women, but needs long-term care.
In 2014, a study was conducted on 24 women with androgenetic alopecia to test the effectiveness of mesotherapy, a treatment involving a combination of micronutrients and antioxidants. The results showed a positive effect on hair growth and thickness, with a slight increase in hair density. However, the effect on hair density was significantly more pronounced in younger women compared to older women. The benefits of mesotherapy were observed for a period of 6-12 months, indicating that the treatment requires long-term care.
4 citations
,
May 2020 in “JAAD case reports” JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.
9 citations
,
January 2020 in “Journal of The European Academy of Dermatology and Venereology” Minoxidil activation by hair enzymes predicts treatment success for female hair loss.
30 citations
,
June 2018 in “Experimental Dermatology” The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.
15 citations
,
January 2018 in “Journal of Dermatological Treatment” Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.
70 citations
,
July 2016 in “Experimental Dermatology” A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.
3 citations
,
January 2016 in “Annals of Dermatology” Minoxidil was the most effective treatment for hair regrowth in rats compared to Aminexil or Kerium.
January 2015 in “PubMed” Mesotherapy, a treatment with micronutrients and antioxidants, improves hair growth and thickness, especially in younger women, but needs long-term care.
August 2014 in “Journal of drug discovery and therapeutics” 
165 citations
,
August 2013 in “Lasers in Surgery and Medicine” Low-Level Laser Therapy is effective and safe for hair growth with minimal side effects.
January 2007 in “Strait Pharmaceutical Journal”
